- Home
- ASPS vs ELDN Comparison
ASPS vs ELDN Comparison
Compare ASPS & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- ELDN
- Stock Information
- Founded
- ASPS 1999
- ELDN 2004
- Country
- ASPS Luxembourg
- ELDN United States
- Employees
- ASPS N/A
- ELDN N/A
- Industry
- ASPS Other Consumer Services
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- ELDN Health Care
- Exchange
- ASPS Nasdaq
- ELDN Nasdaq
- Market Cap
- ASPS 150.8M
- ELDN 178.4M
- IPO Year
- ASPS N/A
- ELDN N/A
- Fundamental
- Price
- ASPS $11.50
- ELDN $3.62
- Analyst Decision
- ASPS
- ELDN Strong Buy
- Analyst Count
- ASPS 0
- ELDN 2
- Target Price
- ASPS N/A
- ELDN $12.50
- AVG Volume (30 Days)
- ASPS 40.2K
- ELDN 890.7K
- Earning Date
- ASPS 07-24-2025
- ELDN 08-18-2025
- Dividend Yield
- ASPS N/A
- ELDN N/A
- EPS Growth
- ASPS N/A
- ELDN N/A
- EPS
- ASPS N/A
- ELDN N/A
- Revenue
- ASPS $168,271,000.00
- ELDN N/A
- Revenue This Year
- ASPS $38.29
- ELDN N/A
- Revenue Next Year
- ASPS N/A
- ELDN N/A
- P/E Ratio
- ASPS N/A
- ELDN N/A
- Revenue Growth
- ASPS 12.96
- ELDN N/A
- 52 Week Low
- ASPS $3.46
- ELDN $2.38
- 52 Week High
- ASPS $15.96
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- ASPS 50.42
- ELDN 59.47
- Support Level
- ASPS $12.22
- ELDN $3.63
- Resistance Level
- ASPS $14.21
- ELDN $3.95
- Average True Range (ATR)
- ASPS 1.69
- ELDN 0.24
- MACD
- ASPS -0.29
- ELDN 0.01
- Stochastic Oscillator
- ASPS 27.00
- ELDN 49.73
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.